JPWO2019169015A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019169015A5 JPWO2019169015A5 JP2020567470A JP2020567470A JPWO2019169015A5 JP WO2019169015 A5 JPWO2019169015 A5 JP WO2019169015A5 JP 2020567470 A JP2020567470 A JP 2020567470A JP 2020567470 A JP2020567470 A JP 2020567470A JP WO2019169015 A5 JPWO2019169015 A5 JP WO2019169015A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- asthma
- antibody
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862636092P | 2018-02-27 | 2018-02-27 | |
| US62/636,092 | 2018-02-27 | ||
| PCT/US2019/019872 WO2019169015A1 (en) | 2018-02-27 | 2019-02-27 | Anti cd6 antibodies for treating severe asthma |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021515039A JP2021515039A (ja) | 2021-06-17 |
| JP2021515039A5 JP2021515039A5 (https=) | 2022-03-07 |
| JPWO2019169015A5 true JPWO2019169015A5 (https=) | 2022-03-07 |
| JP7572041B2 JP7572041B2 (ja) | 2024-10-23 |
Family
ID=65724591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020567470A Active JP7572041B2 (ja) | 2018-02-27 | 2019-02-27 | 重症喘息を処置するための組成物および方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20210380711A1 (https=) |
| EP (1) | EP3759140A1 (https=) |
| JP (1) | JP7572041B2 (https=) |
| KR (1) | KR20200128415A (https=) |
| CN (1) | CN112424226B (https=) |
| AU (1) | AU2019228508A1 (https=) |
| BR (1) | BR112020017445A2 (https=) |
| CA (1) | CA3091920A1 (https=) |
| IL (1) | IL276875A (https=) |
| MX (1) | MX2020008916A (https=) |
| PH (1) | PH12020551323A1 (https=) |
| SG (1) | SG11202008149RA (https=) |
| WO (1) | WO2019169015A1 (https=) |
| ZA (1) | ZA202005320B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA201001467A1 (ru) | 2008-03-14 | 2011-06-30 | Биокон Лимитед | Моноклональное антитело и способ его использования |
| CA2920368C (en) | 2013-07-23 | 2023-03-21 | Centro De Inmunologia Molecular | Use of a cd6 binding partner and method based thereon |
| PL3529274T3 (pl) | 2016-10-21 | 2024-09-09 | Biocon Limited | Przeciwciało monoklonalne i sposób jego stosowania w leczeniu tocznia |
| US20230151107A1 (en) * | 2020-04-04 | 2023-05-18 | Biocon Limited | Anti-cd6 antibody compositions and methods for treating and reducing negative effects of a coronavirus including covid-19 |
| AU2021392748A1 (en) * | 2020-12-04 | 2023-06-29 | Equillium, Inc. | Methods of selectively targeting cd6 high cells and decreasing activity of t eff cells |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5462990A (en) * | 1990-10-15 | 1995-10-31 | Board Of Regents, The University Of Texas System | Multifunctional organic polymers |
| CU22615A1 (es) | 1994-06-30 | 2000-02-10 | Centro Inmunologia Molecular | Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos |
| CU22584A1 (es) | 1995-11-17 | 1999-11-03 | Centro Inmunologia Molecular | Composiciones farmacéuticas que contienen un anticuerpo monoclonal que reconoce el antígeno de diferenciación leucocitario humano cd6 y sus usos para el diagnóstico y tratamiento de la psoriasis |
| CA2282410A1 (en) | 1997-03-03 | 1998-10-01 | Bristol-Myers Squibb Company | Monoclonal antibodies to human cd6 |
| KR101482959B1 (ko) | 2006-12-26 | 2015-01-15 | 센트로 데 인뮤놀러지아 모레큘러 | Ｂ-세포 만성 림프구성 백혈병의 진단 및 치료에 유용한 종양 세포에서 세포사멸을 유도할 수 있는 약학 조성물 |
| EA201001467A1 (ru) | 2008-03-14 | 2011-06-30 | Биокон Лимитед | Моноклональное антитело и способ его использования |
| CN102559636B (zh) * | 2011-12-30 | 2014-03-12 | 百泰生物药业有限公司 | 用于白血病和自身免疫疾病的抗体融合蛋白及其制备方法 |
| JP6296650B2 (ja) | 2013-03-13 | 2018-03-20 | 国立大学法人 筑波大学 | 免疫疾患に対する医薬組成物 |
| JP2017507939A (ja) | 2014-02-21 | 2017-03-23 | ジェネンテック， インコーポレイテッド | 抗ｉｌ−１３／ｉｌ−１７二重特異性抗体及びその使用 |
| CA2992262A1 (en) | 2015-07-15 | 2017-01-19 | Kyowa Hakko Kirin Co., Ltd. | Antibody which specifically binds to human crth2 |
| WO2017218750A1 (en) * | 2016-06-15 | 2017-12-21 | The Cleveland Clinic Foundation | Novel anti-cd6 antibodies for treating t-cell mediated conditions |
| JP7065085B2 (ja) * | 2016-10-18 | 2022-05-11 | バイオコン・リミテッド | Ｃｄ６のリン酸化を低減させるためのイトリズマブの使用 |
-
2019
- 2019-02-27 SG SG11202008149RA patent/SG11202008149RA/en unknown
- 2019-02-27 US US16/976,298 patent/US20210380711A1/en not_active Abandoned
- 2019-02-27 CN CN201980027155.5A patent/CN112424226B/zh active Active
- 2019-02-27 JP JP2020567470A patent/JP7572041B2/ja active Active
- 2019-02-27 AU AU2019228508A patent/AU2019228508A1/en not_active Abandoned
- 2019-02-27 WO PCT/US2019/019872 patent/WO2019169015A1/en not_active Ceased
- 2019-02-27 BR BR112020017445-9A patent/BR112020017445A2/pt not_active IP Right Cessation
- 2019-02-27 EP EP19710274.2A patent/EP3759140A1/en active Pending
- 2019-02-27 MX MX2020008916A patent/MX2020008916A/es unknown
- 2019-02-27 CA CA3091920A patent/CA3091920A1/en active Pending
- 2019-02-27 KR KR1020207027953A patent/KR20200128415A/ko not_active Ceased
-
2020
- 2020-08-23 IL IL276875A patent/IL276875A/en unknown
- 2020-08-25 PH PH12020551323A patent/PH12020551323A1/en unknown
- 2020-08-26 ZA ZA2020/05320A patent/ZA202005320B/en unknown
-
2024
- 2024-06-10 US US18/739,089 patent/US20250034272A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021515039A5 (https=) | ||
| AU2013305945B2 (en) | Methods for treating or preventing asthma by administering an IL-4R antagonist | |
| EP4198055A1 (en) | Antibody of il-11 and use thereof | |
| CA2918105C (en) | Methods for reducing exacerbation rates of asthma using benralizumab | |
| KR101627605B1 (ko) | 염증성 장애 치료용 조성물 및 방법 | |
| CN101977935A (zh) | 用于治疗和监测il-13相关病症的方法和组合物 | |
| KR20070033998A (ko) | Ｉｌ-13 결합제 | |
| JP7160533B2 (ja) | 多発性骨髄腫（ｍｍ）の処置 | |
| JP2017507945A5 (https=) | ||
| EP3574919A1 (en) | Methods and compositions for treating asthma using anti-il-13 antibodies | |
| JP2025122028A (ja) | Ｉｌ－３３アンタゴニストを投与することにより喘息を治療するまたは予防するための方法 | |
| US20200231666A1 (en) | Treatment paradigm | |
| JP2020504135A5 (https=) | ||
| AU2023278017A1 (en) | Combination therapies for the treatment of cancer | |
| JPWO2019169015A5 (https=) | ||
| CN118103068A (zh) | 用抗ilt3抗体治疗急性髓系白血病的方法 | |
| JPWO2022076462A5 (https=) | ||
| JP2024525870A (ja) | 抗ｐｌａ２ｒ自己抗体媒介膜性腎症の治療 | |
| US20260008865A1 (en) | Antibodies, compositions, and methods of treatment | |
| CN116635422A (zh) | 抗cd38抗体及其用途 | |
| JPWO2021026021A5 (https=) | ||
| AU2023278019A1 (en) | Combination therapies for the treatment of non-small cell lung cancer | |
| TW202529811A (zh) | 胸腺基質淋巴細胞生成素（ｔｓｌｐ）結合片段之組成物及其使用方法 | |
| RU2020130563A (ru) | Антитела к cd6 для лечения тяжелой астмы | |
| WO2026053166A1 (en) | Anti-il5r-alpha treatment for acute exacerbations of asthma and copd |